Medical Services International to Make Its VScan Rapid Test Kit for the Detection of Tuberculosis Available to the Passengers of Czech Airlines

NEW YORK, June 11 /PRNewswire-FirstCall/ -- Medical Services International Inc. (Pink Sheets: MSITF) wishes to announce that it will make available, at no cost, every 3 months for the next two years its VScan rapid test kit for Tuberculosis (TB) to all passengers and crew that can verify that they were on the Czech Airlines flight from Prague to Montreal where the individual had Tuberculosis (TB).

The VScan TB rapid test kit is a screening test that will tell the individual using it if they have gone from inactive to active TB status. The VScan TB test kit is faster and easier than conventional testing. The VScan TB rapid test kit only detects "live" TB and does NOT give false positives. It is the only kit that does not give false positives. There is no test available that is more accurate. It will detect a change in status from inactive to active (live) status faster than conventional testing. Current testing available other than the VScan TB test gives false positives 30% of the time. Using the VScan rapid test kit does not mean that individuals should ignore the advice of their doctor.

As it will take a significant amount of time before the status of the individuals can be determined, the Company feels that having the availability of its VScan TB test kit will reduce some of the anxiety associated with this situation. For further information please call (780) 430 6363.

About VScan

The VScan rapid test kit is a single use, disposable, accurate, cost effective, easy to use, test for the screening of HIV 1&2, Tuberculosis (TB), Hepatitis B&C, Dengue Fever, West Nile, Syphilis, Malaria and Prostate Cancer. The kits cannot be sold in Canada.

Medical Services International Inc. trades in the United States on the NQB Pink Sheets under the symbol "MSITF". For further information, please contact Robert Talbot at (780) 430 6363 or http://www.medicalservicesintl.com or http://www.minerva-biotech.com.

NOTE: Certain statements in this press release are "forward-looking statements" within the meaning of the Private Securities Act of 1995. Such statements involve known and unknown risks, uncertainties and other factors that may cause results to differ materially.

Such risks, uncertainties and other factors include but are not limited to new economic conditions, risk in product development, market acceptance of new products and continuing product demand, level of competition and other factors described in Company reports and other filings with regulatory bodies.